Clinical Trials Logo

Clinical Trial Summary

Multicentre, pivotal, non-randomized, prospective, open-label clinical investigation involving a new hydrogel, Hy2Care Injectable hydrogel, developed by Hy2Care B.V., Enschede, The Netherlands (hereafter referred to as "Hy2Care") to treat cartilage defects (< 2 cm2) in the human knee. The product aims at functional repair of cartilage defects in the knee and regeneration of cartilage. The objective of this clinical investigation is to demonstrate the clinical safety and performance of the Hy2Care Injectable hydrogel. Data from this clinical investigation will be used to support a CE marking application for the Hy2Care Injectable hydrogel. Sites will be selected based on a documented site qualification procedure. The Principal Investigator at each site will be selected based on confirmed expertise in the orthopaedic field. Each site will have a designated Principal Investigator and one or more study coordinators collectively responsible for the study data collection, inclusive of screening, enrolment, evaluation and documentation, in accordance with the International Organization for Standardization (ISO) 14155 guidelines for Good Clinical Practice. Per site, one physician will be assigned as Principal Investigator. Other physicians will be referred to as 'sub-investigators'.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05186935
Study type Interventional
Source Hy2Care BV
Contact Sanna Severins, MSc
Phone +31(0)88 999 5700
Email [email protected]
Status Not yet recruiting
Phase Phase 1
Start date February 1, 2022
Completion date October 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03755388 - Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant N/A
Recruiting NCT04716140 - Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery N/A
Recruiting NCT04889443 - Spontaneous Healing of ARticular Cartilage (SHARC)
Enrolling by invitation NCT04118023 - 7T MRI to Evaluate Cartilage Defects in the Knee
Active, not recruiting NCT01473199 - BioPoly RS Knee Registry Study for Cartilage Defect Replacement N/A
Recruiting NCT05082831 - Human ECM Implanted Within Microfracture Interstices & the Cartilage Defect in the Knee to Regenerate Hyaline Cartilage Phase 1
Recruiting NCT05124613 - The Impact of Covid-19 on Patients Waiting for Knee Surgery
Recruiting NCT03873545 - Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
Recruiting NCT04785092 - All Autologous Cartilage Regeneration in the Treatment of the Knee Cartilage Defects N/A
Not yet recruiting NCT02776943 - UCMSC Transplantation in the Treatment of Cartilage Damage Phase 1/Phase 2
Recruiting NCT04236739 - Comparing Clinical Outcomes of the One-step Cartilage Transplantation in Cartilage Defects of the Knee With Conservative Treatment Phase 3
Completed NCT02189408 - Clinical Study of Pain Reduction by Peri-arthroscopic PRP Application in Knee Degeneration Phase 4
Recruiting NCT04626999 - Single and Double Bundle ACL Reconstructions, in Term of Cartilage Damage Due to Remaining Instability After Surgery. N/A
Recruiting NCT04301258 - ProChondrix® CR Articular Cartilage Restoration Evaluation (PACE) Registry
Not yet recruiting NCT04875767 - Cartilage Repair Using a Hyaluronic Acid-Based Scaffold With Bone Marrow Aspirate Compared With Microfracture for Focal Articular Cartilage Damage of the Hip N/A
Terminated NCT04212650 - Losartan to Improve Hip Microfracture Phase 1/Phase 2
Not yet recruiting NCT02640144 - The Influence of Hyaluronic Acid Injection Following Knee Arthroscopy Phase 4